Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo

Detalles Bibliográficos
Autores principales: Liu, Jia, Dong, Bing-Fei, Wang, Pei-Song, Ren, Pei-You, Xue, Shuai, Zhang, Xiao-Nan, Han, Zhe, Chen, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931839/
https://www.ncbi.nlm.nih.gov/pubmed/35234269
http://dx.doi.org/10.3892/or.2022.8297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931839/
https://www.ncbi.nlm.nih.gov/pubmed/35234269
http://dx.doi.org/10.3892/or.2022.8297

Ejemplares similares